About JLK
JLK Inc. is a pioneering medical AI company that develops comprehensive artificial intelligence solutions for medical imaging analysis, with particular expertise in neurological disorders and stroke management. Founded in 2014 and headquartered in Seoul, South Korea, JLK became the first company in the AI medical industry to list on the KOSDAQ exchange in December 2019. The company's flagship product, MEDIHUB STROKE, provides an end-to-end AI-based stroke management solution covering all clinical protocol steps from emergency room to rehabilitation for both hemorrhagic and ischemic stroke patients. JLK's technology analyzes multiple imaging modalities including CT, CTA, CTP, MRI, and MRA images. Beyond stroke, the company has expanded into chest X-ray analysis (JVIEWER-X), mammography screening (JBD-01K), prostate cancer detection, and dementia assessment. JLK has secured over 78 global medical AI licenses across major markets including FDA clearance in the United States, PMDA approval in Japan, CE certification in Europe, and MFDS approval in Korea. The company holds more than 96 core technology patents and has been designated for innovative medical device status in Korea. JLK also operates Hello Data, an AI medical data management platform that supports data processing for medical imaging, autonomous driving, and manufacturing industries. With subsidiaries in the United States (Silicon Valley), Japan (Tokyo), and a drug discovery subsidiary JLK BIO, the company serves health systems, hospitals, and medical institutions globally. JLK's mission is to accompany the journey of life with knowledge, driving innovation through AI technology to establish a new paradigm in medical diagnostics and healthcare delivery.
Mission & Story
Mission
JLK accompanies journey of life with knowledge. We will quantum leap to be the global #1 AI company with incessant development and challenges.
Founding Story
JLK was founded with the spirit of challenge and technology to overcome impossibility, pioneering innovative technologies for conquering neurological diseases and cancer. The company name represents 'Journey of Life with Knowledge.'
Clinical Focus
Medical conditions and clinical areas addressed by JLK.
Who It Serves
Milestones & Awards
Recent Milestones
Launched FASTRO integrated mobile medical app (December 2024). FDA clearances for JLK-ICH, JLK-AILink, JLK-PWI, JLK-LVO, JLK-CTP, Medihub Prostate (2024-2025). PMDA approvals for multiple solutions including JLK-SWI, JLK-GRE, JLK-FLAIR, JLK-DWI, JLK-NCCT (2025). Designated as Outstanding R&D Innovation Product by MSIT (2025). First AI Medical Imaging Device in Korea to receive non-reimbursed coverage (2023).
Awards & Recognition
Minister's Award at AI Convergence Acceleration Project Report (2023). Minister's Award at 24th Software Industry Day (2023). Award by Minister of Ministry of Health and Welfare (2018). Award by Minister of Ministry of Science Information and Communication (2019). First company to go public in AI medical industry (2019). Designated as Innovative Medical Device in Korea (first among AI medical devices, 2022). Innovative medical device company designated by Ministry of Health and Welfare of Korea (2022). Designated as Innovative Procurement Product Korea (2024).
Key Partnerships
Company Details
- Founded
- 2014
- Headquarters
- Seoul, Gangnam-gu, South Korea
- Employees
- 51-200
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.